Adjuvant chemotherapy in elderly patients: An analysis of national cancer institute of Canada clinical trials group and intergroup JBR.10

被引：0
|
作者：
Pepe, C.
Hasan, B.
Winton, T.
Seymour, L.
Pater, J.
Livingston, R.
Johnson, D.
Rigas, J.
Ding, K.
Shepherd, F. A.
机构：
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2006年 / 60卷
关键词：
D O I：
10.1016/S1040-8428(13)70021-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S6 / S7
页数：2
相关论文
共 50 条
  • [1] Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10
    Pepe, Carmela
    Hasan, Baktiar
    Winton, Timothy L.
    Seymour, Lesley
    Graham, Barbara
    Livingston, Robert B.
    Johnson, David H.
    Rigas, James R.
    Ding, Keyue
    Shepherd, Frances A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) : 1553 - 1561
  • [2] Adjuvant chemotherapy in elderly patients: An analysis of National Cancer Institute of Canada Clinical Trials Group and intergroup BRAD.
    Pepe, C.
    Hasan, B.
    Winton, T.
    Seymour, L.
    Pater, J.
    Livingston, R.
    Johnson, D.
    Rigas, J.
    Ding, K.
    Shepherd, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 366S - 366S
  • [3] Quality-Adjusted Time Without Symptoms or Toxicity Analysis of Adjuvant Chemotherapy in Non-Small-Cell Lung Cancer: An Analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 Trial
    Jang, Raymond W.
    Le Maitre, Aurelie
    Ding, Keyue
    Winton, Tim
    Bezjak, Andrea
    Seymour, Lesley
    Shepherd, Frances A.
    Leighl, Natasha B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) : 4268 - 4273
  • [4] Pathologic determinants of survival for adjuvant treatment of stage IB non-small cell lung cancer (NSCLC): an analysis of the National Cancer Institute of Canada (NCIC) and Intergroup Study JBR.10
    Strevel, Elizabeth L.
    Ding, Keyue
    Seymour, Lesley
    Tsao, Ming S.
    Le Maitre, Aurelie
    Shepherd, Frances A.
    Burkes, Ronald L.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S333 - S334
  • [5] An economic analysis of National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) JBR.10, a randomized trial of adjuvant vinorelbine plus cisplatin versus observation in early stage non-small cell lung cancer (NSCLC).
    Ng, R.
    Mittmann, N.
    Florescu, M.
    Shepherd, F. A.
    Salvarrey, A.
    Seymour, L.
    Winton, T.
    Evans, B.
    Leighl, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 402S - 402S
  • [6] Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer - An analysis of National Cancer Institute of Canada and intergroup trial JBR. 10 and a review of the literature
    Alam, N
    Shepherd, FA
    Winton, T
    Graham, B
    Johnson, D
    Livingston, R
    Rigas, J
    Whitehead, M
    Ding, K
    Seymour, L
    LUNG CANCER, 2005, 47 (03) : 385 - 394
  • [7] Economic analysis of NCIC CTG JBR.10: A randomized trial of adjuvant vinorelbine plus cisplatin compared with observation in early stage non-small-cell lung cancer - A report of the working group on economic analysis, and the lung disease site group, National Cancer Institute of Canada Clinical Trials Group
    Ng, Raymond
    Hasan, Baktiar
    Mittmann, Nicole
    Florescu, Marie
    Shepherd, Frances A.
    Ding, Keyue
    Butts, Charles Andrew
    Cormier, Yvon
    Darling, Gail
    Goss, Glenwood D.
    Inculet, Richard
    Seymour, Lesley
    Winton, Timothy L.
    Evans, William K.
    Leighl, Natasha B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (16) : 2256 - 2261
  • [8] Class III beta tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: Analysis of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) study JBR.10.
    Reiman, T.
    Lai, R.
    Ding, K.
    Winton, T.
    Butts, C.
    Mackey, J.
    Dabbagh, L.
    Seymour, L.
    Tsao, M.
    Shepherd, F.
    Seve, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 376S - 376S
  • [9] Anticoagulation and bleeding: A pooled analysis of lung cancer trials of the National Cancer Institute of Canada Clinical Trials Group
    Le Maitre, A.
    Ding, K.
    Shepherd, F. A.
    Leighl, N. B.
    Arnold, A.
    Seymour, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] A 15-gene expression signature prognostic for survival and predictive for adjuvant chemotherapy benefit in JBR.10 patients
    Tsao, M. S.
    Zhu, C.
    Ding, K.
    Strumpf, D.
    Pintilie, M.
    Meyerson, M.
    Seymour, L.
    Jurisica, I.
    Shepherd, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345